Infoglim MV 1mg/500mg/0.2mg Tablet SR
Marketer
Vats Biotech Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Infoglim MV 1mg/500mg/0.2mg Tablet SR
Infoglim MV 1mg/500mg/0.2mg SR tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Administer Infoglim MV with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them. Regular meals and readily available fast-acting glucose sources (e.g., sugary foods, fruit juice) are essential. Alcohol consumption should be minimized due to its hypoglycemic risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is possible. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before initiating treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (for blood counts and liver function) are recommended.
Uses of Infoglim MV 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Infoglim MV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Infoglim MV 1mg/500mg/0.2mg Extended-Release Tablets on an empty stomach.
Common Side effects of Infoglim MV 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Infoglim MV 1mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Infoglim MV 1mg/500mg/0.2mg Extended-Release Tablets on an empty stomach.
How Infoglim MV 1mg/500mg/0.2mg Tablet SR works:
Infoglim MV SR tablets (1mg/500mg/0.2mg) contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Infoglim MV 1mg/500mg/0.2mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Infoglim MV 1mg/500mg/0.2mg SR tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against the risks before prescribing this medication. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet Infoglim MV (1mg/500mg/0.2mg) is likely unsafe for breastfeeding mothers. Available data from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Infoglim MV 1mg/500mg/0.2mg sustained-release tablets carries a high risk of adverse effects in individuals with impaired kidney function and should be strictly avoided. Medical advice is necessary. Furthermore, this medication is unsuitable for patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Infoglim MV 1mg/500mg/0.2mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Infoglim MV 1mg/500mg/0.2mg Tablet SR :
Should you forget to take your Infoglim MV 1mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Infoglim MV 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently